Glutathione S-transferase genotype GSTM1 as a predictor of elevated angiogenic phenotype in patients with early onset breast cancer

Angiogenesis

Volumn 7, Issue 1, 2004, Pages 53-58

  Medeiros, Rui ^a,b   Soares, Raquel ^a,b,c   Vasconcelos, André ^a,b   Schmitt, Fernando ^b,c   Lopes, Carlos ^a,b  

^a INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^b PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

angiogenesis; breast cancer; genotypes; glutathione; GST; pharmacogenomic

Indexed keywords

GENOMIC DNA; GLUTATHIONE TRANSFERASE;

ADULT; ANGIOGENESIS; ARTICLE; BLOOD CELL; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; ENZYME POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

ADULT; AGE OF ONSET; BREAST NEOPLASMS; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS;

EID: 4344595867     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:AGEN.0000037330.20121.d8     Document Type: Article

References (45)

1. Folkman J. What is the evidence that tumours are angiogenesis dependent? J Natl Cancer Inst 1990; 82: 4-6.
2. Marson LP, Miller WR, Dixon JM. Angiogenesis and Breast Cancer. Breast 1998; 7: 299-307.
3. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis (review). Cell 1996; 86: 353-64.
4. Folkman J. Seminars in Medicine of The Beth Israel Hospital, Boston. Clinical Applications of research on angiogenesis. N Engl J Med 1995; 333: 1757-63.
5. Mallery SR, Lantry LE, Laufman HB et al. Modulation of human microvascular endothelial cell bioenergetic status and glutathione levels during proliferative and differentiated growth. J Cell Biochem 1993; 53: 360-72.
6. Schwartz JL, Shklar G. Glutathione inhibits experimental oral carcinogenesis, p53 expression, and angiogenesis. Nutr Cancer 1996; 26: 229-31.
7. Chen C, Liu Q, Relling MV. Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics 1996; 6: 187-90.
8. Bell D, Taylor J, Paulson D et al. Genetic risk and carcinogenic exposure: A common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increase susceptibility to bladder cancer. J Natl Cancer Inst 1996; 85: 1159-63.
9. Marinho A, Soares R, Ferro J et al. Angiogenesis in breast cancer is related to age but not to other prognostic parameters. Path Res Pract 1997; 193: 267-73.
10. Miliaras D, Kamas A, Kalekou H. Angiogenesis in invasive breast carcinoma: Is it associated with parameters of prognostic significance? Histopathology 1995; 26: 165-9.
11. Bosari S, Lee AK, Delellis RA et al. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992; 23: 755-61.
12. Weidner N, Folkman J, Pozza F et al. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992; 84: 1875-87.
13. Weidner N, Semple JP, Welche WR, Folkman J. Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
14. Miller AS, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
15. Brien ML, Tew KD. Glutathione and related enzymes in multidrug resistance. Eur J Cancer 1996; 32A: 967-78.
16. Medeiros R, Pereira D, Afonso N, Lopes C. Susceptibility to breast and ovarian cancer: The role of glutathione S-transferase polymorphism. Eur J Cancer 1999; 35: 737.
17. Weidner N. Tumoural vascularity as a prognostic factor in cancer patients: The evidence continues to grow. J Pathol 1998; 184: 119-22.
18. Guidi AJ, Berry DA, Broadwater G et al. Association of angiogenesis in lymph node metastases with outcome of breast cancer. J Natl Cancer Inst 2000; 92: 486-92.
19. Kato T, Kameoka S, Kimura T et al. Angiogenesis and blood vessel invasion as prognostic indicators for node-negative breast cancer. Breast Cancer Res Treat 2001; 65: 203-15.
20. Kato T, Kameoka S, Kimura T et al. Angiogenesis as a predictor of long-term survival for 377 Japanese patients with breast cancer. Breast Cancer Res Treat 2001; 70: 65-74.
21. Lee AHS. The relationship of vasculariy of the primary tumour to lymph node metastases and to distant haematogenous spread in carcinoma of the breast. Histopathology 2002; 41: 366-386.
22. Klauber-DeMore N, Zee KJ, Linkov I et al. Biological behavior of human breast cancer micrometastases. Clin Cancer Res 2001; 7: 2434-9.
23. Hlatky L, Hahnfeldt P, Folkman J. Clinical application of antiangiogenic therapy: Microvessel density, what it does and doesn't tell us. J Natl Cancer Inst 2002; 94: 883-93.
24. Kerbel R, Folkman J. Clinical translation of angiogenesis inhibitors. Nature Rev Cancer 2002; 2: 727-39
25. Haddad J, Olver R, Land S. Antioxidant/pro-oxidant equilibrium regulates HIF-1α activity and NF-kB redox sensitivity. J Biol Chem 2000; 275: 21130-9.
26. Bicknell R. An update of new targets for cancer treatment: Vessels and matrix. Ann Oncol 2002; 13 (S4): 25-8.
27. Ambrosone CB, Sweeney C, Coles BF et al. Polymorphism in glutathione S-transferases (GSTM1 and GSTT1) and survival after treatment for breast cancer. Cancer Res 2001; 61: 7130-5.
28. Griffioen AW, Molema G. Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 2000; 52: 237-68.
29. Oehler MK, Bicknell R. The promise of anti-angiogenic cancer therapy. Br J Cancer 2000; 82: 749-52.
30. Fan TP, Jaggar R, Bicknell R. Controlling the vasculature: Angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. Trends Pharmacol Sci 1995; 16: 57-66.
31. Nor JE, Christensen J, Mooney DJ, Polverini PJ. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 1999; 154: 375-84.
32. Nor JE, Mitra RS, Sutorik MM et al. Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway. J Vasc Res 2000; 37: 209-18.
33. Coradini D, Pellizzaro C, Veneroni S et al. Infiltrating ductal and lobular breast carcinomas are characterised by different interrelationships among markers related to angiogenesis and hormone dependence. Br J Cancer 2002; 87: 1105-11.
34. Byrne GJ, Bundred NJ. Surrogate markers of tumoral angiogenesis. Int J Biol Markers 2000; 15: 334-9.
35. Thompson WD. Tumour versus patient: Vascular and tumour survival versus prognosis. J Pathol 2001; 193: 425-6.
36. Gould VE, Wagner BM. Angiogenesis: An expanding universe. Hum Pathol 2002; 33: 1061-3.
37. Costa C, Soares R, Reis-Filho JS et al. Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J Clin Pathol 2002; 55 (6): 429-34.
38. Reis-Filho JS, Milanezi F, Schmitt FC. Maspin is expressed in the nuclei of breast myoepithelial cells. J Pathol 2002; 197 (2): 272-3.
39. Reis-Filho JS, Schmitt FC. Lymphangiogenesis in tumors: What do we know? Microsc Res Tech 2003; 60 (2): 171-80.
40. Balasubramanian SP, Brown NJ, Reed MWR. Role of genetic polymorphisms in tumour angiogenesis. Br J Cancer 2002; 87: 1057-65.
41. Medeiros R, Morais A, Vasconcelos A et al. Outcome in prostate cancer: Association with endothelial nitric oxide synthase glu-asp298 polymorphism at exon 7. Clin Cancer Res 2002; 8: 3433-7.
42. Medeiros R, Morais A, Vasconcelos A et al. Linkage between polymorphisms in the prostate specific antigen ARE1 gene region, prostate cancer risk, and circulating tumor cells. Prostate 2002; 53: 88-94.
43. Vasconcelos A, Medeiros R, Veiga I et al. Analysis of estrogen receptor polymorphism in codon 325 by PCR-SSCP in breast cancer: Association with lymph node metastasis. Breast J 2002; 8: 226-9.
44. Medeiros R, Morais A, Vasconcelos A et al. Endothelial nitric oxide synthase gene polymorphisms and the shedding of circulating tumour cells in the blood of prostate cancer patients. Cancer Lett 2003; 189: 85-90.
45. Srivastava A, Laidler P, Davies RP et al. The prognostic significance of tumour vascularity in intermediate thickness (0.76-4.0 mm thick) skin melanoma - a quantitative histologic study. Am J Pathol 1988; 133: 419-23.